Plasma levels of uric acid, urea and creatinine in diabetics who visit the clinical analysis laboratory (CAn-Lab) at Kwame Nkrumah University of science and technology, Kumasi, Ghana

Journal of Clinical and Diagnostic Research

Volumn 9, Issue 2, 2015, Pages BC05-BC09

  Amartey, N A A ^a   Nsiah, K ^a   Mensah, F O ^a  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

Author keywords

Creatinine; Diabetes; Kidney dysfunction; Urea; Uric acid

Indexed keywords

CREATININE; UREA; URIC ACID;

ABDOMINAL PAIN; ADULT; AGE; AGED; ARTICLE; BACKACHE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DISEASE DURATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; MALE; QUESTIONNAIRE; URINARY DYSFUNCTION;

EID: 84922238982     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: 10.7860/JCDR/2015/10905.5530     Document Type: Article

References (27)

1. Smyth S, and Heron A. Diabetes and obesity the twin epidemic, Nat Med. 2006;12:75-80.
2. Yach D, Stucker D, Brownell KD. Epidermiologic and economic consequences of global epidemics of obesity and diabetes.Nat Med. 2006;12:62-66.
3. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub- Saharan Africa. Lancet. 2010;375:2254-66.
4. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in sub-Saharan Africa 1999-2011: Epidemiology and public health implications. a systematic review. BMC Public Health.2011;11:564-65.
5. Gyesie A. Living a healthy and normal life with diabetes. In: Health Care Tit-bits. Accra: Health Care Services Limited, 1992.
6. Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diab Res Clin Pract.2002;56(3):197-205.
7. Ghana Health Service. Ashanti Region: Annual Report, 2006.
8. Karla SP. A case for new therapy for diabetes, is it leptin? [Editorial] Indian J Endocrinol Metab 2012;16(suppl 3):S525-27.
9. Kahan SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003;46(1):3-19.
10. Newsholme P, Karuse M Nutritional Regulation of Insulin Secretion: Implications for Diabetes. Clin Biochem Rev. 2012;33(2):35-47.
11. Caprio S, Tamborlane WV. Metabolic impact of obesity in childhood. Endocrinol Metab Clin North Am.1999;28(4):731-47.
12. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among US adults. Diabetics Care. 2004;27:2444-49.
13. El Nahas AM, Bello AK. Chronic kidney disease: the global challenge. Lancet.2005;365: 331-40.
14. Gupta D, Krueger CB, Lastra G. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction. Curr Diabetes Rev. 2012;8:76-83.
15. Wei W, Liu Q, Tan Y, Liu L, Li X, Cai L. Oxidative stress, diabetes, and diabetic complications. Hemoglobin. 2009;33:370-77.
16. Hunt JV, Dean RT, Wolff SP. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J. 1988;256:205-12.
17. Cholongitas E, Shusang V, Marelli L, Nair D, Thomas M, Patch D. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther. 2007;26:969-78.
18. Arneson W, Brickell J. Clinical Chemistry - A laboratory Perspective,1st edition, F.A Davis company, Philadelphia, 2007; pp. 225-52.
19. Meyer TW, Hostetter TH. Uremia. N Engl J Med. 2007;357(13):1316-25.
20. Wallace KI, Riedel AA, Joseph-Ridge N, Wortman R. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol. 2004;31:1582-87.
21. Choi HK, Atkinson K, Karlson EW, Carham G. Obesity, weight change, hyperuricemia, diuretic use and risk of gout in men, Arch Intern Med. 2005; 165:742-48.
22. Stryer L, Tymoczko JL, Berg J. Biochemistry, 5th edition, W.H. Freeman and company, New York, pp. 1997;324- 50.
23. Griffin KA, Kramer H, Bidani AK. Adverse renal consequences of obesity. Am J Physiol Renal Physiol. 2008;294:F685-96.
24. Bo S, Carallo-Perm, P, Gentile L, Pepetti E, Pagano G. Hyperuricemia in type 2 diabetes: two different phenotypes. Eur J Clin Invest. 2001;31:318-21.
25. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
26. Feig DI, Kang D, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359: 1811-21.
27. Baldwin WMS, Marek G, Wymer D, Pannu V, Baylis C, Johnson RJ, Sautin YY. Hyperuricemia as a mediator of the proinflammatory endocrine imbalance in the adipose tissue in a murine model of the metabolic syndrome. Diabetes. 2011;60(4):1258-69.